(Q37956399)

25 August 2017

Serotonergic anti-obesity agents: past experience and future prospects (English)

1 reference

lorcaserin hydrochloride hemihydrate

25 August 2017

0 references

1 reference

ChEBI release 2020-05-28

4

John E Blundell

1 reference

25 August 2017

3

Clare L Lawton

1 reference

25 August 2017

Emma J Boyland

2

0 references

author name string

Jason C G Halford

series ordinal

1

1 reference

25 August 2017

Joanne A Harrold

series ordinal

5

1 reference

25 August 2017

language of work or name

1 reference

1 December 2011

1 reference

25 August 2017

1 reference

25 August 2017

71

1 reference

25 August 2017

17

1 reference

25 August 2017

2247-2255

1 reference

https://scigraph.springernature.com/pub.10.2165/11596680-000000000-00000

25 August 2017

0 references

cites work

Quantification of the effect of energy imbalance on bodyweight

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Predictors of weight maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Overconsumption and obesity: peptides and susceptibility to weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Gastric capacity, test meal intake, and appetitive hormones in binge eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Experimental studies on food-intake in obese and normal weight subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Laboratory eating behavior in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Eating fast leads to obesity: findings based on self-administered questionnaires among middle-aged Japanese men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

The joint impact on being overweight of self reported behaviours of eating quickly and eating until full: cross sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Eating rate is a heritable phenotype related to weight in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Fasting leptin and appetite responses induced by a 4-day 65%-energy-restricted diet

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Psychological effects of dieting.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Psychological consequences of food restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

The psychology of food craving

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Characterization of obese individuals who claim to detect no relationship between their eating pattern and sensations of hunger or fullness.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Eating behaviors and indexes of body composition in men and women from the Québec family study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

The association of body weight, dietary intake, and energy expenditure with dietary restraint and disinhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

The Eating Inventory and body adiposity from leanness to massive obesity: a study of 2509 adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Resistance and susceptibility to weight gain: individual variability in response to a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Activation of central melanocortin pathways by fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Central serotonin and melanocortin pathways regulating energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Separate systems for serotonin and leptin in appetite control

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

A behavioural profile of fluoxetine-induced anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

CP-94, 253: a selective serotonin1B (5-HT1B) agonist that promotes satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Reversal of sibutramine-induced anorexia with a selective 5-HT(2C) receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Male and female 5-HT(1B) receptor knockout mice have higher body weights than wildtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Effect of anorexic drugs on food intake and the micro-structure of eating in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Serotoninergic manipulation, meal-induced satiety and eating pattern: effect of fluoxetine in obese female subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

m-Chlorophenylpiperazine decreases food intake in a test meal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

5-HT2C receptor activation decreases appetite and body weight in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

The efficacy and safety of sibutramine for weight loss: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Drug management of obesity--efficacy versus safety

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Relationships of psychiatric disorders with overweight and obesity in an adult general population

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Multicenter, placebo-controlled trial of lorcaserin for weight management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Lorcaserin--not a new weapon in the battle with appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Tesofensine – a novel potent weight loss medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

The debate over dopamine's role in reward: the case for incentive salience

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

The effect of the triple monoamine reuptake inhibitor tesofensine on energy metabolism and appetite in overweight and moderately obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Food selection and eating behaviour during weight maintenance intervention and 2-y follow-up in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Serotonin Reciprocally Regulates Melanocortin Neurons to Modulate Food Intake

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Serotonergic drugs : effects on appetite expression and use for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596680-000000000-00000

Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

12 December 2020

The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects

1 reference

12 December 2020

Eating behavior correlates of adult weight gain and obesity in healthy women aged 55-65 y.

1 reference

12 December 2020

Sibutramine reduces food intake in non-dieting women with obesity

1 reference

12 December 2020

Is there a role for serotonin (5-hydroxytryptamine) in feeding?

1 reference

12 December 2020

Thermogenic effects of sibutramine in humans

1 reference

12 December 2020

The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks

1 reference

12 December 2020

An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats

1 reference

12 December 2020

Psychometric properties and factor structure of the Three-Factor Eating Questionnaire (TFEQ) in obese men and women. Results from the Swedish Obese Subjects (SOS) study

1 reference

12 December 2020

Characterisation of adjustments to the structure of feeding behaviour following pharmacological treatment: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and methergoline

1 reference

12 December 2020

Eating in public places: a review of reports of the direct observation of eating behavior

1 reference

12 December 2020

Modalities of the food intake-reducing effect of sibutramine in humans

1 reference

12 December 2020

Tesofensine, a monoamine reuptake inhibitor for the treatment of obesity

1 reference

12 December 2020

Eating behaviour in obese and normal weight 11-year-old children

1 reference

12 December 2020

Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials

1 reference

12 December 2020

Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity

1 reference

12 December 2020

Differential effect of d-fenfluramine and metergoline on food intake in human subjects

1 reference

12 December 2020

Socioeconomic gradient in body size and obesity among women: the role of dietary restraint, disinhibition and hunger in the Whitehall II study

1 reference

12 December 2020

Association of body mass with dietary restraint and disinhibition

1 reference

12 December 2020

Sensitivity of the appetite control system in obese subjects to nutritional and serotoninergic challenges

1 reference

12 December 2020

Differential brain responses to satiation in obese and lean men

1 reference

12 December 2020

The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence

1 reference

12 December 2020

10.2165/11596680-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

25 August 2017

0 references

1 reference